nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—PTGS2—Triamcinolone—alopecia areata	0.749	1	CbGbCtD
Thalidomide—PTGS2—Fluocinonide—Triamcinolone—alopecia areata	0.00999	0.624	CbGdCrCtD
Thalidomide—NFKB1—IL23-mediated signaling events—CXCL9—alopecia areata	0.00912	0.0643	CbGpPWpGaD
Thalidomide—NFKB1—Selenium Micronutrient Network—PRDX5—alopecia areata	0.00844	0.0595	CbGpPWpGaD
Thalidomide—FGFR2—skin epidermis—alopecia areata	0.00784	0.438	CbGeAlD
Thalidomide—TNF—IL23-mediated signaling events—CXCL9—alopecia areata	0.00695	0.049	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—PRDX5—alopecia areata	0.00643	0.0453	CbGpPWpGaD
Thalidomide—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—CTLA4—alopecia areata	0.00636	0.0448	CbGpPWpGaD
Thalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—alopecia areata	0.00603	0.376	CbGdCrCtD
Thalidomide—PTGS1—Selenium Micronutrient Network—PRDX5—alopecia areata	0.00501	0.0353	CbGpPWpGaD
Thalidomide—NFKB1—T-Cell Receptor and Co-stimulatory Signaling—CD8A—alopecia areata	0.00489	0.0345	CbGpPWpGaD
Thalidomide—Thromboembolism—Triamcinolone—alopecia areata	0.00455	0.0603	CcSEcCtD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—CXCL9—alopecia areata	0.00405	0.0285	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—PRDX5—alopecia areata	0.00398	0.028	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—CXCL9—alopecia areata	0.00379	0.0267	CbGpPWpGaD
Thalidomide—Meningitis—Triamcinolone—alopecia areata	0.00373	0.0494	CcSEcCtD
Thalidomide—NFKB1—IL2 signaling events mediated by PI3K—IL2RA—alopecia areata	0.00363	0.0256	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—PRDX5—alopecia areata	0.00351	0.0247	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—CXCL9—alopecia areata	0.00316	0.0223	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—alopecia areata	0.00314	0.0221	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL9—alopecia areata	0.00309	0.0217	CbGpPWpGaD
Thalidomide—NFKB1—TSLP Signaling Pathway—IL2RA—alopecia areata	0.003	0.0211	CbGpPWpGaD
Thalidomide—Embolism venous—Triamcinolone—alopecia areata	0.00287	0.038	CcSEcCtD
Thalidomide—CYP1A1—skin epidermis—alopecia areata	0.00284	0.159	CbGeAlD
Thalidomide—NFKB1—IL12-mediated signaling events—CD8A—alopecia areata	0.00273	0.0193	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—IL2RA—alopecia areata	0.00247	0.0174	CbGpPWpGaD
Thalidomide—FGFR2—skin of body—alopecia areata	0.00243	0.136	CbGeAlD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL9—alopecia areata	0.00241	0.017	CbGpPWpGaD
Thalidomide—PTGS2—skin epidermis—alopecia areata	0.00238	0.133	CbGeAlD
Thalidomide—NFKB1—Adaptive Immune System—ULBP3—alopecia areata	0.00238	0.0167	CbGpPWpGaD
Thalidomide—NFKB1—IL23-mediated signaling events—CD4—alopecia areata	0.00231	0.0163	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—CD4—alopecia areata	0.00227	0.016	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—ULBP3—alopecia areata	0.00225	0.0159	CbGpPWpGaD
Thalidomide—Embolism—Triamcinolone—alopecia areata	0.00225	0.0298	CcSEcCtD
Thalidomide—Tooth disorder—Triamcinolone—alopecia areata	0.00223	0.0295	CcSEcCtD
Thalidomide—TNF—Allograft Rejection—CTLA4—alopecia areata	0.00217	0.0153	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—alopecia areata	0.00217	0.0153	CbGpPWpGaD
Thalidomide—NFKB1—Downstream TCR signaling—CD4—alopecia areata	0.00213	0.015	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—CXCL10—alopecia areata	0.00211	0.0149	CbGpPWpGaD
Thalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—alopecia areata	0.00208	0.0146	CbGpPWpGaD
Thalidomide—Hepatomegaly—Triamcinolone—alopecia areata	0.00204	0.0271	CcSEcCtD
Thalidomide—NFKB1—TCR Signaling Pathway—CD8A—alopecia areata	0.00198	0.0139	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—alopecia areata	0.00194	0.0137	CbGpPWpGaD
Thalidomide—Neuritis—Triamcinolone—alopecia areata	0.00194	0.0257	CcSEcCtD
Thalidomide—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—alopecia areata	0.00193	0.0136	CbGpPWpGaD
Thalidomide—TNF—IL23-mediated signaling events—CD4—alopecia areata	0.00176	0.0124	CbGpPWpGaD
Thalidomide—Petechiae—Triamcinolone—alopecia areata	0.00176	0.0233	CcSEcCtD
Thalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IL2RA—alopecia areata	0.00174	0.0123	CbGpPWpGaD
Thalidomide—Acne—Triamcinolone—alopecia areata	0.00172	0.0228	CcSEcCtD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—CXCL10—alopecia areata	0.00165	0.0116	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL10—alopecia areata	0.00161	0.0113	CbGpPWpGaD
Thalidomide—NFKB1—TCR signaling—CD4—alopecia areata	0.00159	0.0112	CbGpPWpGaD
Thalidomide—Arthropathy—Triamcinolone—alopecia areata	0.00159	0.0211	CcSEcCtD
Thalidomide—NFKB1—IL12-mediated signaling events—CD4—alopecia areata	0.00157	0.0111	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—IL2RA—alopecia areata	0.00154	0.0109	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—IL2RA—alopecia areata	0.00151	0.0106	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—ULBP3—alopecia areata	0.00144	0.0102	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—CXCL10—alopecia areata	0.00143	0.0101	CbGpPWpGaD
Thalidomide—Candida infection—Triamcinolone—alopecia areata	0.00138	0.0183	CcSEcCtD
Thalidomide—Skin exfoliation—Triamcinolone—alopecia areata	0.00138	0.0183	CcSEcCtD
Thalidomide—FGFR2—Immune System—ULBP3—alopecia areata	0.00137	0.00964	CbGpPWpGaD
Thalidomide—Neuropathy—Triamcinolone—alopecia areata	0.00136	0.018	CcSEcCtD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—alopecia areata	0.00134	0.00947	CbGpPWpGaD
Thalidomide—Pulmonary oedema—Triamcinolone—alopecia areata	0.00129	0.0171	CcSEcCtD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL10—alopecia areata	0.00125	0.00884	CbGpPWpGaD
Thalidomide—Euphoric mood—Triamcinolone—alopecia areata	0.00124	0.0165	CcSEcCtD
Thalidomide—Thrombophlebitis—Triamcinolone—alopecia areata	0.00121	0.0161	CcSEcCtD
Thalidomide—Diabetes mellitus—Triamcinolone—alopecia areata	0.00121	0.016	CcSEcCtD
Thalidomide—Vascular purpura—Triamcinolone—alopecia areata	0.00117	0.0155	CcSEcCtD
Thalidomide—Cardiac failure congestive—Triamcinolone—alopecia areata	0.00116	0.0153	CcSEcCtD
Thalidomide—Injury—Triamcinolone—alopecia areata	0.00114	0.0151	CcSEcCtD
Thalidomide—NFKB1—TCR Signaling Pathway—CD4—alopecia areata	0.00114	0.008	CbGpPWpGaD
Thalidomide—Increased appetite—Triamcinolone—alopecia areata	0.00112	0.0148	CcSEcCtD
Thalidomide—Dermatitis bullous—Triamcinolone—alopecia areata	0.0011	0.0146	CcSEcCtD
Thalidomide—Purpura—Triamcinolone—alopecia areata	0.00109	0.0144	CcSEcCtD
Thalidomide—Osteoarthritis—Triamcinolone—alopecia areata	0.00105	0.0139	CcSEcCtD
Thalidomide—Affect lability—Triamcinolone—alopecia areata	0.00103	0.0137	CcSEcCtD
Thalidomide—Cardiac arrest—Triamcinolone—alopecia areata	0.000998	0.0132	CcSEcCtD
Thalidomide—Mood swings—Triamcinolone—alopecia areata	0.000994	0.0132	CcSEcCtD
Thalidomide—Muscular weakness—Triamcinolone—alopecia areata	0.000926	0.0123	CcSEcCtD
Thalidomide—Abdominal distension—Triamcinolone—alopecia areata	0.000913	0.0121	CcSEcCtD
Thalidomide—Influenza—Triamcinolone—alopecia areata	0.000907	0.012	CcSEcCtD
Thalidomide—Pancreatitis—Triamcinolone—alopecia areata	0.000889	0.0118	CcSEcCtD
Thalidomide—PTGS2—Spinal Cord Injury—CXCL10—alopecia areata	0.000885	0.00624	CbGpPWpGaD
Thalidomide—CYP1A1—skin of body—alopecia areata	0.00088	0.0492	CbGeAlD
Thalidomide—Bronchitis—Triamcinolone—alopecia areata	0.000872	0.0116	CcSEcCtD
Thalidomide—Upper respiratory tract infection—Triamcinolone—alopecia areata	0.000843	0.0112	CcSEcCtD
Thalidomide—Weight increased—Triamcinolone—alopecia areata	0.000826	0.0109	CcSEcCtD
Thalidomide—Acute coronary syndrome—Triamcinolone—alopecia areata	0.000797	0.0106	CcSEcCtD
Thalidomide—Myocardial infarction—Triamcinolone—alopecia areata	0.000793	0.0105	CcSEcCtD
Thalidomide—Neuropathy peripheral—Triamcinolone—alopecia areata	0.000793	0.0105	CcSEcCtD
Thalidomide—Conjunctivitis—Triamcinolone—alopecia areata	0.000786	0.0104	CcSEcCtD
Thalidomide—PTGS1—skin of body—alopecia areata	0.000773	0.0432	CbGeAlD
Thalidomide—Epistaxis—Triamcinolone—alopecia areata	0.000763	0.0101	CcSEcCtD
Thalidomide—Bradycardia—Triamcinolone—alopecia areata	0.000739	0.0098	CcSEcCtD
Thalidomide—PTGS2—skin of body—alopecia areata	0.000739	0.0413	CbGeAlD
Thalidomide—Rhinitis—Triamcinolone—alopecia areata	0.000728	0.00965	CcSEcCtD
Thalidomide—Pharyngitis—Triamcinolone—alopecia areata	0.000721	0.00955	CcSEcCtD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—IL2RA—alopecia areata	0.000719	0.00507	CbGpPWpGaD
Thalidomide—Arrhythmia—Triamcinolone—alopecia areata	0.000649	0.0086	CcSEcCtD
Thalidomide—Dysgeusia—Triamcinolone—alopecia areata	0.000619	0.0082	CcSEcCtD
Thalidomide—Back pain—Triamcinolone—alopecia areata	0.000611	0.0081	CcSEcCtD
Thalidomide—Ill-defined disorder—Triamcinolone—alopecia areata	0.000586	0.00777	CcSEcCtD
Thalidomide—Angioedema—Triamcinolone—alopecia areata	0.000578	0.00765	CcSEcCtD
Thalidomide—Malaise—Triamcinolone—alopecia areata	0.00057	0.00755	CcSEcCtD
Thalidomide—Vertigo—Triamcinolone—alopecia areata	0.000568	0.00753	CcSEcCtD
Thalidomide—Syncope—Triamcinolone—alopecia areata	0.000567	0.00751	CcSEcCtD
Thalidomide—PTGS2—C-MYB transcription factor network—CD4—alopecia areata	0.000565	0.00399	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CTLA4—alopecia areata	0.000558	0.00394	CbGpPWpGaD
Thalidomide—Loss of consciousness—Triamcinolone—alopecia areata	0.000556	0.00736	CcSEcCtD
Thalidomide—Cough—Triamcinolone—alopecia areata	0.000552	0.00731	CcSEcCtD
Thalidomide—Convulsion—Triamcinolone—alopecia areata	0.000548	0.00726	CcSEcCtD
Thalidomide—Hypertension—Triamcinolone—alopecia areata	0.000546	0.00723	CcSEcCtD
Thalidomide—Myalgia—Triamcinolone—alopecia areata	0.000538	0.00713	CcSEcCtD
Thalidomide—Discomfort—Triamcinolone—alopecia areata	0.000532	0.00705	CcSEcCtD
Thalidomide—FGFR2—Adaptive Immune System—CTLA4—alopecia areata	0.00053	0.00373	CbGpPWpGaD
Thalidomide—Dry mouth—Triamcinolone—alopecia areata	0.000526	0.00697	CcSEcCtD
Thalidomide—Oedema—Triamcinolone—alopecia areata	0.000516	0.00684	CcSEcCtD
Thalidomide—Infection—Triamcinolone—alopecia areata	0.000512	0.00679	CcSEcCtD
Thalidomide—Shock—Triamcinolone—alopecia areata	0.000508	0.00673	CcSEcCtD
Thalidomide—Tachycardia—Triamcinolone—alopecia areata	0.000503	0.00667	CcSEcCtD
Thalidomide—Hyperhidrosis—Triamcinolone—alopecia areata	0.000499	0.00661	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Triamcinolone—alopecia areata	0.00047	0.00623	CcSEcCtD
Thalidomide—Insomnia—Triamcinolone—alopecia areata	0.000467	0.00618	CcSEcCtD
Thalidomide—Paraesthesia—Triamcinolone—alopecia areata	0.000463	0.00614	CcSEcCtD
Thalidomide—Dyspnoea—Triamcinolone—alopecia areata	0.00046	0.00609	CcSEcCtD
Thalidomide—Dyspepsia—Triamcinolone—alopecia areata	0.000454	0.00602	CcSEcCtD
Thalidomide—Fatigue—Triamcinolone—alopecia areata	0.000445	0.00589	CcSEcCtD
Thalidomide—Pain—Triamcinolone—alopecia areata	0.000441	0.00585	CcSEcCtD
Thalidomide—NFKB1—Adaptive Immune System—CD8A—alopecia areata	0.000429	0.00303	CbGpPWpGaD
Thalidomide—Feeling abnormal—Triamcinolone—alopecia areata	0.000425	0.00563	CcSEcCtD
Thalidomide—Urticaria—Triamcinolone—alopecia areata	0.00041	0.00543	CcSEcCtD
Thalidomide—Body temperature increased—Triamcinolone—alopecia areata	0.000408	0.0054	CcSEcCtD
Thalidomide—FGFR2—Adaptive Immune System—CD8A—alopecia areata	0.000407	0.00287	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL9—alopecia areata	0.000381	0.00269	CbGpPWpGaD
Thalidomide—Hypersensitivity—Triamcinolone—alopecia areata	0.00038	0.00504	CcSEcCtD
Thalidomide—Asthenia—Triamcinolone—alopecia areata	0.00037	0.0049	CcSEcCtD
Thalidomide—Pruritus—Triamcinolone—alopecia areata	0.000365	0.00484	CcSEcCtD
Thalidomide—FGFR2—Signaling Pathways—CXCL9—alopecia areata	0.000362	0.00255	CbGpPWpGaD
Thalidomide—Dizziness—Triamcinolone—alopecia areata	0.000341	0.00452	CcSEcCtD
Thalidomide—NFKB1—Immune System—CTLA4—alopecia areata	0.000339	0.00239	CbGpPWpGaD
Thalidomide—Vomiting—Triamcinolone—alopecia areata	0.000328	0.00435	CcSEcCtD
Thalidomide—Rash—Triamcinolone—alopecia areata	0.000325	0.00431	CcSEcCtD
Thalidomide—Dermatitis—Triamcinolone—alopecia areata	0.000325	0.00431	CcSEcCtD
Thalidomide—Headache—Triamcinolone—alopecia areata	0.000323	0.00428	CcSEcCtD
Thalidomide—FGFR2—Immune System—CTLA4—alopecia areata	0.000321	0.00227	CbGpPWpGaD
Thalidomide—Nausea—Triamcinolone—alopecia areata	0.000306	0.00406	CcSEcCtD
Thalidomide—NFKB1—Immune System—CD8A—alopecia areata	0.00026	0.00184	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—CD4—alopecia areata	0.000257	0.00181	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD8A—alopecia areata	0.000247	0.00174	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—CD4—alopecia areata	0.000247	0.00174	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCR3—alopecia areata	0.000246	0.00173	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—CD4—alopecia areata	0.000244	0.00172	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—IL2RA—alopecia areata	0.000235	0.00165	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—CD4—alopecia areata	0.000234	0.00165	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCR3—alopecia areata	0.000233	0.00164	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—IL2RA—alopecia areata	0.000223	0.00157	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL10—alopecia areata	0.000199	0.0014	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL10—alopecia areata	0.000188	0.00133	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—IL2RA—alopecia areata	0.000152	0.00107	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—CD4—alopecia areata	0.00015	0.00105	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—IL2RA—alopecia areata	0.000144	0.00102	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—CD4—alopecia areata	0.000142	0.001	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CD4—alopecia areata	0.000131	0.000924	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CD4—alopecia areata	6.51e-05	0.000459	CbGpPWpGaD
